カンザス州における乳がんの臨床試験
カンザス州内の拠点で、乳がんに関する26件の研究が参加者を募集しています。
カンザス州内の都市
公式研究テキスト（英語）
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Central Care Cancer Center - Garden City, Garden City
- Central Care Cancer Center - Great Bend, Great Bend
- Veteran Administration Eastern Kansas Healthcare, Leavenworth
- 他4件
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
- The University of Kansas Cancer Center, Westwood
被験者募集中第3相
60歳以上 · 全性別 · 2026/09/25更新 · NCT06377852A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
- Cancer Center of Kansas, Wichita
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/15更新 · NCT06492616Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
- University of Kansas Hospital-Cancer Center, Fairway
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/04更新 · NCT07287917Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
- University of Kansas Cancer Center, Westwood
- Cancer Center of Kansas, Wichita
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/03更新 · NCT06982521Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
- Central Care Cancer Center - Garden City, Garden City
- Central Care Cancer Center - Great Bend, Great Bend
- HaysMed, Hays
- 他10件
被験者募集中第3相
18歳〜60歳 · 女性 · 2026/09/02更新 · NCT05879926Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
- AMR Kansas City Oncology, Kansas City
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/02更新 · NCT06072612Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry
- Hays Medical Center Dreiling-Schmidt Cancer Institute, Hays
- KCCC West, Kansas City
- KCCC Overland Park, Overland Park
- 他3件
被験者募集中観察研究健康なボランティア歓迎
全年齢 · 全性別 · 2026/08/18更新 · NCT02302742Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
- University of Kansas Cancer Center, Kansas City
- University of Kansas Cancer Center-Overland Park, Overland Park
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/17更新 · NCT06500481Sequencing Antibody Drug Conjugates in ER+/HER2 LOW/ULTRA LOW MBC
- University of Kansas Medical Center, Fairway
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/12更新 · NCT06263543Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
- University of Kansas Cancer Center, Kansas City
被験者募集中第2相健康なボランティア歓迎
45歳〜74歳 · 女性 · 2026/08/04更新 · NCT06195306Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- University of Kansas Medical Center (KUMC), Westwood
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/04更新 · NCT05579366E-Mindfulness Approaches for Living After Breast Cancer
- Cotton O'Neil Cancer Center / Stormont Vail Health, Topeka
被験者募集中第3相
18歳〜50歳 · 全性別 · 2026/08/04更新 · NCT06748222Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
- University of Kansas Cancer Center, Kansas City
被験者募集中第2相
18歳〜55歳 · 女性 · 2026/07/27更新 · NCT06184750HER2-positive Breast Cancer Registry
- The University of Kansas Cancer Center, Westwood
被験者募集中観察研究
18歳以上 · 全性別 · 2026/07/17更新 · NCT06603597Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
- University of Kansas Cancer Center, Kansas City
被験者募集中第2相
35歳以上 · 女性 · 2026/07/07更新 · NCT05941520Integrated Cancer Repository for Cancer Research
- Saint Luke's Cancer Instititute - South, Overland Park
被験者募集中観察研究健康なボランティア歓迎
19歳〜110歳 · 全性別 · 2026/06/29更新 · NCT02012699Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
- The University of Kansas Cancer Center, Westwood
被験者募集中第3相
18歳以上 · 全性別 · 2026/05/18更新 · NCT06757634Trial of Neoadjuvant THP vs TCHP for HER2-Amplified/Positive Breast Cancer
- The University of Kansas Cancer Center (KUCC), Fairway
- The University of Kansas Cancer Center - Westwood, Kansas City
- KUCC - Indian Creek, Overland Park
- 他3件
被験者募集中第2相
18歳以上 · 全性別 · 2026/05/06更新 · NCT07220135De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
- University of Kansas Cancer Center, Kansas City
- The University of Kansas Cancer Center - Olathe, Olathe
- University of Kansas Cancer Center-Overland Park, Overland Park
- 他8件
被験者募集中第3相
50歳〜70歳 · 全性別 · 2026/04/23更新 · NCT04852887Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis
- The University of Kansas Cancer Center, Westwood
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/04/20更新 · NCT06374459Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- HaysMed, Hays
- Lawrence Memorial Hospital, Lawrence
- The University of Kansas Cancer Center - Olathe, Olathe
- 他6件
被験者募集中観察研究
18歳以上 · 全性別 · 2026/03/17更新 · NCT06418204EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
- University of Kansas Cancer Center, Westwood
被験者募集中観察研究
18歳以上 · 全性別 · 2026/01/20更新 · NCT06401421Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer
- Cancer Center of Kansas, Wichita
被験者募集中第2相
18歳以上 · 全性別 · 2025/11/10更新 · NCT04553770High Risk Breast Clinic: Protocol for Women at Increased Risk for Developing Breast Cancer
- University of Kansas Medical Center, Kansas City
被験者募集中観察研究健康なボランティア歓迎
30歳〜65歳 · 女性 · 2025/10/29更新 · NCT00291096S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
- HaysMed University of Kansas Health System, Hays
- University of Kansas Cancer Center-West, Kansas City
- University of Kansas Cancer Center, Kansas City
- 他5件
被験者募集中第3相
18歳以上 · 全性別 · 2025/10/08更新 · NCT03418961ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。